STAT

Opinion: Why Trump’s opioid plan falls short

President Trump's plan to combat the opioid epidemic falls short of delivering approaches that would make a real difference, says former Obama drug czar Michael Botticelli.
President Trump speaks about the opioid crisis in Manchester, N.H., Monday.

President Trump’s long-delayed plan to combat the nation’s opioid epidemic, announced in a Monday speech in New Hampshire, led with a headline-grabbing call: impose the death penalty on drug dealers.

This emphasis on capital punishment only underscores the president’s over-reliance on supply reduction and law enforcement efforts, two strategies that have failed to produce meaningful change in a public health crisis that claimed more than 63,000 lives in the U.S. in 2016.

While law enforcement

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks